Trial Number

471-24

Condition

Stroke

Participant Age Range

18 years and older

Participant Gender

Any

Enrolling Participants

Yes

Overview

“A multicenter, double-blinded, placebo-controlled, single ascending dose, two-part, randomized clinical trial to assess safety, tolerability, pharmacokinetics (PK) and pharmacodynamics (PD) of BB-031 in acute ischemic stroke (AIS) patients”

The purpose of this study is to evaluate the safety and tolerability of ascending doses (Part A) and selected doses (Part B) of BB-031 in acute ischemic stroke patients presenting within 24 hours of stroke onset.

Provider

Nirav S Patel, MD

Neurology
Long Beach, Los Alamitos
View Profile

Location

Long Beach Medical Center

2801 Atlantic Avenue
Long Beach
(562) 933-2000
Location Details

Related Clinical Trials

Click on the category you are interested in.

Stroke Care Long Beach Medical Center
Name
Enter Trial number from the area just below the marquee.
How would you prefer to be contacted?
How did you hear about us?
This registration is for:
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.